114 related articles for article (PubMed ID: 14565327)
1. Urinary modified nucleosides as tumor markers.
Dudley E; Lemiere F; Van Dongen W; Esmans E; El-Sharkawi AM; Games DE; Brenton AG; Newton RP
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):987-9. PubMed ID: 14565327
[TBL] [Abstract][Full Text] [Related]
2. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
[TBL] [Abstract][Full Text] [Related]
3. Analysis of urinary nucleosides. II. Comparison of mass spectrometric methods for the analysis of urinary nucleosides.
Dudley E; Lemiere F; Van Dongen W; Langridge JI; El-Sharkawi S; Games DE; Esmans EL; Newton RP
Rapid Commun Mass Spectrom; 2001; 15(18):1701-7. PubMed ID: 11555869
[TBL] [Abstract][Full Text] [Related]
4. Analysis of urinary nucleosides. V. Identification of urinary pyrimidine nucleosides by liquid chromatography/electrospray mass spectrometry.
Bond A; Dudley E; Lemière F; Tuytten R; El-Sharkawi S; Brenton AG; Esmans EL; Newton RP
Rapid Commun Mass Spectrom; 2006; 20(2):137-50. PubMed ID: 16331740
[TBL] [Abstract][Full Text] [Related]
5. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
[TBL] [Abstract][Full Text] [Related]
6. Analysis of modified nucleosides in the urine of patients with malignant cancer by liquid chromatography/electrospray ionization mass spectrometry.
Li HY; Wang SM; Liu HM; Li J; Han D; Bu SS; Zhang MZ
Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3161-71. PubMed ID: 18798199
[TBL] [Abstract][Full Text] [Related]
7. Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis.
Jeng LB; Lo WY; Hsu WY; Lin WD; Lin CT; Lai CC; Tsai FJ
Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1543-9. PubMed ID: 19399767
[TBL] [Abstract][Full Text] [Related]
8. Analysis of urinary nucleosides as potential cancer markers determined using LC-MS technique.
Struck-Lewicka W; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2014 Dec; 101():50-7. PubMed ID: 24840632
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer.
Bullinger D; Fröhlich H; Klaus F; Neubauer H; Frickenschmidt A; Henneges C; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B
Anal Chim Acta; 2008 Jun; 618(1):29-34. PubMed ID: 18501242
[TBL] [Abstract][Full Text] [Related]
10. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography tandem mass spectrometry study of urinary nucleosides as potential cancer markers.
Struck W; Siluk D; Yumba-Mpanga A; Markuszewski M; Kaliszan R; Markuszewski MJ
J Chromatogr A; 2013 Mar; 1283():122-31. PubMed ID: 23465127
[TBL] [Abstract][Full Text] [Related]
12. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
[TBL] [Abstract][Full Text] [Related]
13. Separation and identification of purine nucleosides in the urine of patients with malignant cancer by reverse phase liquid chromatography/electrospray tandem mass spectrometry.
Li HY; Wang SM; Liu HM; Bu SS; Li J; Han D; Zhang MZ; Wu GY
J Mass Spectrom; 2009 May; 44(5):641-51. PubMed ID: 19142897
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry based methods for analysis of nucleosides as antiviral drugs and potential tumor biomarkers.
Agrofoglio LA; Bezy V; Chaimbault P; Delépée R; Rhourri B; Morin P
Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1523-7. PubMed ID: 18066819
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometry analysis of nucleosides and nucleotides.
Dudley E; Bond L
Mass Spectrom Rev; 2014; 33(4):302-31. PubMed ID: 24285362
[TBL] [Abstract][Full Text] [Related]
16. Urinary nucleosides.
Schram KH
Mass Spectrom Rev; 1998; 17(3):131-251. PubMed ID: 10095827
[TBL] [Abstract][Full Text] [Related]
17. [Significance of urinary nucleosides in diagnosis of gastric carcinoma].
Chen YJ; Zheng YF; Wang NF; Lu S; Pang T; Yang Q; Xu GW
Ai Zheng; 2003 May; 22(5):537-40. PubMed ID: 12753721
[TBL] [Abstract][Full Text] [Related]
18. Urinary nucleosides in leukemia: laboratory and clinical applications.
Trewyn RW; Grever MR
Crit Rev Clin Lab Sci; 1986; 24(1):71-93. PubMed ID: 3539520
[TBL] [Abstract][Full Text] [Related]
19. Analysis of urinary nucleosides. IV. Identification of urinary purine nucleosides by liquid chromatography/electrospray mass spectrometry.
Dudley E; Lemière F; Van Dongen W; Tuytten R; El-Sharkawi S; Brenton AG; Esmans EL; Newton RP
Rapid Commun Mass Spectrom; 2004; 18(22):2730-8. PubMed ID: 15499664
[TBL] [Abstract][Full Text] [Related]
20. Analysis of urinary nucleosides. I. Optimisation of high performance liquid chromatography/electrospray mass spectrometry.
Dudley E; El-Sharkawi S; Games DE; Newton RP
Rapid Commun Mass Spectrom; 2000; 14(14):1200-7. PubMed ID: 10918368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
